Glenmark receives USFDA final approval for Sirolimus tablets
Glenmark receives USFDA final approval for Sirolimus tablets

Glenmark receives USFDA final approval for Sirolimus tablets

DSIJ Intelligence Article rating: 3.8

Sirolimus tablets, 0.5 mg, 1 mg, and 2 mg are the generic version of Rapamune tablets, 0.5 mg, 1 mg, and 2 mg, of PF Prism CV. These tablets are used to prevent the rejection of kidney transplants.

NFO Update: quant ESG Equity Fund
NFO Update: quant ESG Equity Fund

NFO Update: quant ESG Equity Fund

DSIJ Intelligence Article rating: 3.1

Quant mutual fund has launched its newly open-ended equity scheme i.e. quant ESG Equity Fund. Read on to find more details.

SBI or SBI Cards & Payment: Whats your choice?
SBI or SBI Cards & Payment: Whats your choice?

SBI or SBI Cards & Payment: Whats your choice?

DSIJ Intelligence Article rating: 4.6

On Monday, Bank Nifty zoomed by around 2.17 per cent and S&P BSE Bankex was up by 2.37 per cent. While banking and financial stocks rally, SBI Cards, and its parent company, SBI is not shy of being favoured by the investors.

Dr Reddys gets nod from DCGI for Sputnik V vaccine trial
Dr Reddys gets nod from DCGI for Sputnik V vaccine trial

Dr Reddys gets nod from DCGI for Sputnik V vaccine trial

DSIJ Intelligence Article rating: 5.0

Dr Reddy’s and RDIF entered into a partnership in early September 2020 to conduct clinical trials and distribution of Sputnik V vaccine in India and as a part of it, RDIF would be delivering 100 million doses of the vaccine to Dr Reddy’s after receiving regulatory approval in India.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

DSIJ Intelligence Article rating: 4.0

The market opened in green October 19, 2020, overall volumes in futures & options currently stand at 2,00,11,511 contracts with a turnover of Rs. 14,48,499.97 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

DSIJ Intelligence Article rating: 4.8

The market opened in green October 19, 2020, overall volumes in futures & options currently stand at 2,00,11,511 contracts with a turnover of Rs. 14,48,499.97 crore.

RSS
First27132714271527162718272027212722Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR